1/12
09:00 am
obio
Orchestra BioMed to Receive Up to $21 Million in Proceeds from Acquisition of Vivasure by Haemonetics
Medium
Report
Orchestra BioMed to Receive Up to $21 Million in Proceeds from Acquisition of Vivasure by Haemonetics
1/9
08:02 am
obio
Orchestra BioMed (NASDAQ:OBIO) had its "overweight" rating reaffirmed by analysts at Barclays PLC.
Medium
Report
Orchestra BioMed (NASDAQ:OBIO) had its "overweight" rating reaffirmed by analysts at Barclays PLC.
12/31
11:21 am
obio
TD Cowen Initiates Orchestra BioMed (OBIO), Cites High-Margin Potential in Lead Cardiovascular Programs [Yahoo! Finance]
Low
Report
TD Cowen Initiates Orchestra BioMed (OBIO), Cites High-Margin Potential in Lead Cardiovascular Programs [Yahoo! Finance]
12/12
06:54 am
obio
Favourable Signals For Orchestra BioMed Holdings: Numerous Insiders Acquired Stock [Yahoo! Finance]
Low
Report
Favourable Signals For Orchestra BioMed Holdings: Numerous Insiders Acquired Stock [Yahoo! Finance]
12/10
08:43 am
obio
Orchestra BioMed (NASDAQ:OBIO) is now covered by analysts at TD Cowen. They set a "buy" rating and a $15.00 price target on the stock.
Medium
Report
Orchestra BioMed (NASDAQ:OBIO) is now covered by analysts at TD Cowen. They set a "buy" rating and a $15.00 price target on the stock.
12/10
07:21 am
obio
Orchestra BioMed (NASDAQ:OBIO) is now covered by analysts at Cowen Inc. They set a "buy" rating on the stock.
High
Report
Orchestra BioMed (NASDAQ:OBIO) is now covered by analysts at Cowen Inc. They set a "buy" rating on the stock.
12/8
07:00 am
obio
Orchestra BioMed Announces AVIM Therapy and Virtue SAB Program Presentations at ICI Meeting
Low
Report
Orchestra BioMed Announces AVIM Therapy and Virtue SAB Program Presentations at ICI Meeting
11/29
01:34 am
obio
Analyst Confidence in Orchestra BioMed Holdings (OBIO) High Amid Key Clinical and Strategic Advancements [Yahoo! Finance]
Medium
Report
Analyst Confidence in Orchestra BioMed Holdings (OBIO) High Amid Key Clinical and Strategic Advancements [Yahoo! Finance]
11/26
05:38 pm
obio
Orchestra BioMed Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) [Yahoo! Finance]
Low
Report
Orchestra BioMed Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) [Yahoo! Finance]
11/26
04:05 pm
obio
Orchestra BioMed Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Low
Report
Orchestra BioMed Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
11/13
09:01 am
obio
Orchestra BioMed (NASDAQ:OBIO) had its "buy" rating reaffirmed by analysts at Chardan Capital. They now have a $20.00 price target on the stock.
Medium
Report
Orchestra BioMed (NASDAQ:OBIO) had its "buy" rating reaffirmed by analysts at Chardan Capital. They now have a $20.00 price target on the stock.
11/12
11:05 am
obio
Orchestra BioMed (NASDAQ:OBIO) had its price target lowered by analysts at Barclays PLC from $12.00 to $11.00. They now have an "overweight" rating on the stock.
Medium
Report
Orchestra BioMed (NASDAQ:OBIO) had its price target lowered by analysts at Barclays PLC from $12.00 to $11.00. They now have an "overweight" rating on the stock.
11/11
09:00 am
obio
Orchestra BioMed to Participate in Upcoming Institutional Investor Conferences
Medium
Report
Orchestra BioMed to Participate in Upcoming Institutional Investor Conferences
11/11
08:22 am
obio
What To Expect From Orchestra BioMed Holdings Inc (OBIO) Q3 2025 Earnings [Yahoo! Finance]
Medium
Report
What To Expect From Orchestra BioMed Holdings Inc (OBIO) Q3 2025 Earnings [Yahoo! Finance]
11/10
04:38 pm
obio
Orchestra BioMed Reports Third Quarter 2025 Financial Results and Highlights Recent Business Updates [Yahoo! Finance]
Medium
Report
Orchestra BioMed Reports Third Quarter 2025 Financial Results and Highlights Recent Business Updates [Yahoo! Finance]
11/10
04:10 pm
obio
Orchestra BioMed Reports Third Quarter 2025 Financial Results and Highlights Recent Business Updates
Medium
Report
Orchestra BioMed Reports Third Quarter 2025 Financial Results and Highlights Recent Business Updates
11/3
08:00 am
obio
Orchestra BioMed to Host Business Update Call on November 12, 2025
Low
Report
Orchestra BioMed to Host Business Update Call on November 12, 2025
10/28
08:00 am
obio
Orchestra BioMed and Terumo Enter into New $30 Million Virtue SAB Strategic Agreements
Medium
Report
Orchestra BioMed and Terumo Enter into New $30 Million Virtue SAB Strategic Agreements
10/27
09:00 am
obio
Orchestra BioMed Announces First Patients Enrolled in Virtue® SAB US Pivotal IDE Coronary Trial
Low
Report
Orchestra BioMed Announces First Patients Enrolled in Virtue® SAB US Pivotal IDE Coronary Trial